Evaluation of bumetanide as a potential therapeutic agent for Alzheimer’s disease

Evaluation of bumetanide as a potential therapeutic agent for Alzheimer’s disease

Therapeutics discovery and development for Alzheimer’s disease (AD) has been an area of intense research to alleviate memory loss and the underlying pathogenic processes. Recent drug discovery approaches have utilized in silico computational strategies for drug candidate selection which has opened t...

Full description

Bibliographic Details
Main Authors: Ben Boyarko, Sonia Podvin, Barry Greenberg, Jeremiah D. Momper, Yadong Huang, William H. Gerwick, Anne G. Bang, Luisa Quinti, Ana Griciuc, Doo Yeon Kim, Rudolph E. Tanzi, Howard H. Feldman, Vivian Hook
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Pharmacology
Subjects:
Alzheimer’s disease
therapeutic
treatment
bumetanide
repurpose
memory
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1190402/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1190402/full

Similar Items